-New Discovery changes Light Therapy-
    Recently, scientists discovered a special kind of cells in our eyes - called melanopsin photoreceptors - that are responsible for using light to regulate our body clocks. These receptors respond to specific wavelengths of light that occur naturally in sunlight. Researchers call these wavelengths the 'action spectrum' because they are so much more powerful than other kinds of light.


-Action Spectrum for Maximum Benefit-
    Apollo has engineered the world's first full-spectrum, 10,000-lux lightbox that produces 100% of the right kind of light. Most traditional light boxes don't produce enough of this action spectrum to be really effective. The briteLITE 6 is engineered to bring the benefits of this new research to the 10,000-lux world. It has 50% more of this effective bandwidth (460-485 nm) than our best-selling briteLITE IV at the same distance.


-The briteLITE 6 is on the Cutting Edge of Light Therapy Research-
    The Brite Lite 6 combines Apollo's patent-pending BRITEWAVE™ and BLUEWAVE™ technologies to produce a brighter, steadier light source, with the ideal wave lengths, color spectrum and intensity for maximum therapeutic results. These technologies are only available from Apollo Health - The Leader in Light Therapy.

                (Patented BRITEWAVE Technology™ is the only technology specifically engineered to stimulate the production of key chemicals, hormones and neurotransmitters created by your body. Only BRITEWAVE creates the ideal wavelength of light, color, and intensity clinically proven effective for those suffering from depressive mood and sleep disorders. All Apollo light therapy devices use BRITEWAVE Technology. BRITEWAVE Technology is the culmination of Apollo's research with leading research universities and institutions since 1987.
                BLUEWAVE Technology™ is the latest evolution in light therapy technology, and is the result of over a decade of research with the National Institute of Health (NIH) and Thomas Jefferson Medical University in Philadelphia. Researchers at TJMU discovered that a specific wavelength of light is more effective than all other wavelengths at treating Seasonal Affective Disorder and other circadian related disorders. This wavelength, known as the 'action spectrum' of light is responsible for suppressing melatonin, shifting circadian rhythms and eliciting an antidepressant response. Apollo Health has contracted with TJMU and the NIH in developing BLUEWAVE Technology--the only method of delivering 100% of this effective bandwidth of light. Because BLUEWAVE provides the effectiveness of light therapy without the added intensity of standard full spectrum light, users can receive all of the benefits of light therapy in less time and with fewer side effects.)


-The First Name in Full-Spectrum, 10,000-lux Light Therapy-
Since 1987, Apollo Health has pioneered the way to better health through light therapy. We have participated in more research and clinical trials than any other light therapy company, and our products have helped hundreds of thousands of people manage their body clocks for better health.